Larvol Delta - atai-Life-Sciences-Announces-Dosing-of-First-Patient-in-Part-2-of-Beckley-Psytechs-Phase-2a-Study-Exploring-BPL003-Adjunctive-to-SSRIs-in-Patients-with-Treatment-Resistant-Depression

5-methoxy-dimethyltryptamine dry-powder intranasal (BPL-003) - Beckley Psytech

https://www.globenewswire.com/news-release/2024/04/24/2868477/0/en/atai-Life-Sciences-Announces-Dosing-of-First-Patient-in-Part-2-of-Beckley-Psytech-s-Phase-2a-Study-Exploring-BPL-003-Adjunctive-to-SSRIs-in-Patients-with-Treatment-Resistant-Depres.html

Apr 24, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next